Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2026-01-02 @ 9:46 AM
Study NCT ID:
NCT01770392
Status:
COMPLETED
Last Update Posted:
2014-11-27
First Post:
2013-01-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Relative Bioavailability of a Single Dose of Nintedanib Given Alone and in Combination With Multiple Doses of Rifampicin
Sponsor:
Boehringer Ingelheim
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy | View |
Keywords: